跳至主要内容
临床试验/ACTRN12619000365167
ACTRN12619000365167尚未招募4 期

A Randomised Trial Comparing Simethicone With No Bowel Prep In Reducing Rectal Variability During Prostate Radiotherapy.

Radiation Oncology Department, Sir Charles Gairdner Hospital0 个研究点目标入组 30 人开始时间: 2019年3月7日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • Patients receiving external beam radiotherapy (ERBT) to the prostate or post-prostatectomy bed +/- pelvic lymph nodes in both cases.
  • Age >18 years
  • Receiving 6 or more weeks of radiotherapy treatment.
  • Life expectancy of at least 12 months
  • Written informed consent for entry into the study.

排除标准

  • History of previous surgery to the bowel.
  • Inflammatory bowel disease.
  • Patients taking levothyroxine - Simethicone given regularly may decrease levothyroxine absorption.

研究者

发起方
Radiation Oncology Department, Sir Charles Gairdner Hospital

相似试验